Open access peer-reviewed chapter - ONLINE FIRST

Recent Trends and Advances in Design of Rapid Tests for Colorimetric Detection of Staphylococcus aureus

Written By

Cemile Yilmaz, Cagla Celik, Nilay Ildiz, Esma Eryilmaz-Eren, Mehmet Akif Dündar, Uner Kayabas and Ismail Ocsoy

Submitted: 29 August 2024 Reviewed: 30 August 2024 Published: 26 September 2024

DOI: 10.5772/intechopen.1007052

Advances and Perspectives of Infections Caused by <em>Staphylococcus aureus</em> IntechOpen
Advances and Perspectives of Infections Caused by Staphylococ... Edited by Jaime Bustos-Martínez

From the Edited Volume

Advances and Perspectives of Infections Caused by Staphylococcus aureus [Working Title]

Dr. Jaime Bustos-Martínez, Dr. Juan José Valdez-Alarcón and Dr. Aida Hamdan-Partida

Chapter metrics overview

10 Chapter Downloads

View Full Metrics

Abstract

Staphylococcus aureus (S. aureus), which is a member of Micrococcacease family, is one of the most dangerous disease-causing bacteria. S. aureus is also the biggest factor causing hospital-acquired infections worldwide, as well as life-threatening infections such as meningitis, septicaemia, and suppurating wounds in the human body. Today, there have been various phenotypic and/or genotypic methods for the detection of both S. aureus and methicillin-resistant S. aureus (MRSA) strains. Although genotypic methods have been commonly used for certain and rapid results, they are quite expensive and rarely available in all hospitals; they need costly and complicated devices and expert use. To address these issues, researchers have recently developed nanomaterials (NMs) and organic molecules-based phenotypic methods for rapid, sensitive, and economical detection of S. aureus and MRSA. We focus on evaluating colorimetric assays using NMs and pH indicator-containing tests for the rapid, sensitive, and cost-effective detection of S. aureus and MRSA, and specifically target their application in both clinical and environmental contexts.

Keywords

  • rapid test
  • phenotypic testing
  • colorimetic response
  • antibiotic resistant bacteria
  • Staphylococcus aureus

1. Introduction

Staphylococcus aureus is a leading pathogen responsible for both community and hospital-associated bacteraemia. It is a facultative anaerobic Gram-positive coccus commonly found as a commensal organism in the respiratory tract and on the skin [1, 2]. Despite its typical role as a harmless colonizer, S. aureus can cause infections ranging from mild skin infections to severe, life-threatening diseases such as bacteraemia. Bacteraemia caused by S. aureus is particularly serious and is associated with high morbidity and mortality, even with appropriate treatment [3]. In paediatric patients, especially those in intensive care units, S. aureus is a significant cause of several infections. Common infections in children include sepsis, toxic shock syndrome, osteomyelitis, septic arthritis, pneumonia, and skin and soft tissue infections. Neonates in intensive care units are particularly vulnerable, with bloodstream infections often associated with umbilical or central venous catheters. Staphylococcal scalded skin syndrome, characterized by generalized erythematous blistering, is particularly severe in neonates due to the lack of protective exotoxin antibodies [4, 5].

The clinical importance of S. aureus is underscored by its role in both community and healthcare settings and the growing challenge of antimicrobial resistance. Methicillin-resistant S. aureus (MRSA) outbreaks in neonatal intensive care units highlight the continued need for robust infection control measures [6]. Epidemiologic data from The Centers for Disease Control and Prevention’s 2023 report indicate that African Americans have higher rates of invasive MRSA infection than Caucasians. The increasing incidence of MRSA in both hospital and community settings underscores the critical need for continued vigilance in infection prevention and management strategies [7].

Advertisement

2. Detection of Staphylococcus aureus

Rapid and accurate detection of bacterial presence, concentration, and identity (type) in the environment, as well as food and clinical samples, is vital for both public health security and early diagnosis of infectious infections [8, 9]. In this sense, there are various classical techniques for the detection and identification of bacterial pathogens. For example, culture and colony counting, immunological approaches, polymerase chain reaction (PCR) and reverse transcriptase polymerase chain reaction (RT-PCR), flow cytometry, mass spectrometry, microarrays, fluorescence-based assay, and electrochemical-based assay have been developed and are still in use. However, although these techniques provide accurate and sensitive results, the most important disadvantages of these techniques are that they are time-consuming, complicated, and laborious, require complicated tools, and are not suitable for field work (portability) [10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22].

A variety of tools including targeting ligand conjugated NPs, enzyme incorporated systems, and paper-based assays, have been developed for colorimetric detection, profiling, and destruction of S. aureus and MRSA. In response to these challenges, recent advancements have focused on developing novel methods utilizing nanomaterials (NMs) and pH indicators for the rapid, sensitive, and economical detection of S. aureus and MRSA. This work aims to explore the efficacy of colorimetric assays and nanomaterial-based approaches for the detection and profiling of S. aureus and MRSA, addressing the need for more accessible, efficient, and portable diagnostic tools. The study seeks to evaluate the performance of these innovative methods in various clinical and environmental contexts, enhancing early detection and improving public health outcomes.

2.1 Nanoparticles-based colorimetric detection of Staphylococcus aureus

In recent years, gold nanoparticles (Au NPs) have been frequently used in the fields of electronics and optics, especially in bioanalytical and biomedical fields, thanks to their unique properties. Au NPs have more advantageous properties than others like easy synthesis, short production time, stable structure (can be stored at focal temperature for a long time), high surface area, easy attachment of functional groups to the surface and most importantly, unique optical properties. Au NPs are used quite actively in applications in the field of bionanotechnology due to their excellent optical properties. Au NPs have begun to be used as biosensors due to the plasmon resonances that they create in the visible region when they interact with light. When Au NPs interact with an analyte, the presence of the analyte and its concentration in the environment can be measured by the change in the optical properties of Au NPs [10, 23, 24, 25, 26, 27, 28, 29].

S. aureus can cause infections ranging from simple food poisoning to life-threatening invasive infections [30]. It can escape the host immune response and causes these infections by producing biofilms and antiphagocytic capsules, persisting intracellularly, and inhibiting leukocyte chemotaxis. S. aureus may cause skin and soft tissue infections (such as impetigo, folliculitis, furuncle, carbuncle, and cellulitis) as well as necrotizing fasciitis by invading muscle and fascia. It infects bones and joints, causing septic arthritis and osteomyelitis. In the literature, S. aureus is reported as a causative agent of severe necrotizing pneumonia in immunocompromised or alcoholic patients [31, 32, 33, 34, 35]. In addition, MRSA is the main causative agent of hospital-acquired invasive infections. It forms a biofilm that causes bacteraemia associated with infections associated with invasive devices (such as intravenous catheters) and difficult-to-treat infections of artificial heart valve endocarditis [36, 37, 38]. MRSA also leads to surgical site infections, one of the most important complications of surgical procedures [39, 40, 41]. S. aureus also has exotoxins. Food poisoning and toxic shock syndrome are infections caused by staph aureus through its toxins [42].

Penicillinase synthesis is present in more than 95% of staphylococcal strains worldwide; therefore, penicillin is not a treatment option. Penicillinase-resistant penicillins (methicillin, nafcillin, and oxacillin) and quinolones may be used in local infections or if susceptible based on antimicrobial resistance test results [43, 44]. First-generation cephalosporins (such as cefazolin and cephalothin) are also options for surgical prophylaxis, depending on local antimicrobial resistance data. Ceftaroline and ceftabiprole are fifth-generation cephalosporins and are effective against MRSA. Methicillin-resistant bacteria are resistant to all beta-lactams, including cephalosporins [45, 46, 47]. Vancomycin is a glycopeptide and should be the first choice in the presence of MRSA bacteraemia or penicillin allergy in MSSA. Teicoplanin is another glycopeptide that penetrates tissues better than vancomycin [48]. Daptomycin is a cyclic lipopeptide antibiotic and is effective against biofilm. Indicated for MRSA bacteraemia if vancomycin-induced nephrotoxicity is present [49, 50]. Dalbavancin and oritavancin are lipoglycopeptide antibiotics newly approved by the FDA for skin and skin structure infections caused by MRSA [51]. Linezolid is a bacteriostatic antibiotic that can be used to treat MRSA bacteraemia, skin infections and pneumonia where other treatments are contraindicated [52]. In biofilm-associated infections such as endocarditis and osteomyelitis, combination therapy with rifampin or aminoglycosides may be considered [53].

S. aureus is a pyogenic bacteria and is seen with many polymorphonuclear leukocytes in the staining of samples taken from the infection site. It grows rapidly on blood agar, forming cream and gold colonies and causing beta haemolysis. Although the gold standard method for diagnosis is culture, it requires a long time. Rapid tests are needed. MALDI-TOF is a common system used routinely to identify S. aureus from positive blood cultures. Fluorescent-based tests that detect antigens and anti-S. aureus antibodies, tissue rapid PCR detection tests, are rapid tests that are in the development phase. Detection of aureus exotoxins in foods and milk is important for the food industry [54, 55, 56].

Recent advancements in nanotechnology are revolutionizing early and precise diagnostics in healthcare. Biosensors based on NMs integrate critical elements such as bioreceptors, transducers, signal processors, and display mechanisms. These sensors benefit from the extensive surface areas and enhanced conductivity of NMs, which enable effective, robust, and reliable biomolecule detection [57]. For instance, the use of Au and silver (Ag) nanomaterials in colorimetric sensors has shown significant improvements in detecting pathogens like MRSA. These NMs amplify colorimetric signals through mechanisms like aggregation, morphological changes, and surface reactions, offering an expanded surface area for biomolecular probe attachment, which enhances signal strength and overall detection accuracy [58]. Various types of sensors, including electrochemical, fluorescent, and mechanical, have been developed to identify MRSA biomarkers, demonstrating effective performance in clinical environments [59].

Colorimetric sensors based on NMs stand out for their ease of use and visual clarity, allowing results to be interpreted without complex instrumentation. NM-based colorimetric sensors combine traditional and innovative techniques, significantly enhancing detection capabilities. The limitations of conventional colorimetric tests, which often suffer from sensitivity and specificity issues, are mitigated by the use of metallic NPs. These NPs provide large surface areas that improve colour change detection and signal clarity by facilitating the binding of recognition molecules like antibodies or enzymes [60].

The application of NMs for pathogen detection is particularly prominent in colorimetric assays. These sensors utilize the electrostatic aggregation properties of NPs to induce detectable colour changes. Au and Ag NPs are particularly effective in this role, enabling straightforward visual detection [61]. Recent reviews highlight the potential of NP-based colorimetric sensors for detecting S. aureus, emphasizing their heightened sensitivity and specificity. By leveraging the high surface-to-volume ratio and reactivity of metal NPs, these sensors offer rapid and accurate pathogen detection through observable colorimetric shifts [62]. Plasmonic NPs are central to the development of rapid colorimetric sensors for bacterial pathogen detection. These sensors generally rely on colour changes caused by NP aggregation or anti-aggregation effects. However, external variables can sometimes lead to false positives, affecting the reliability and selectivity of the methods [58]. To improve performance, innovative approaches such as anti-aggregation techniques and chemical etching are used to refine the plasmonic properties of the NPs. These advancements enhance the sensors’ ability to detect pathogens like S. aureus swiftly, sensitively, and cost-effectively [57].

Yuan et al. [63] developed an Au NP-based colorimetric sensor for detecting S. aureus using aptamer recognition and tiramine signal amplification (TSA). Biotinylated aptamers specifically bind S. aureus to microtitre plates. Through TSA, a large amount of catalase enzyme binds to the bacteria’s surface, accelerating H2O2 consumption and turning the solution blue. In the absence of the target bacterium, the solution turns red. The sensor is highly selective for S. aureus because the aptamers bind specifically to unique surface markers on S. aureus, distinguishing it from other bacteria. This method offers a faster and more sensitive alternative compared to other techniques, with a detection sensitivity of 9 CFU mL−1 for S. aureus.

Shahbazi et al. [59] developed a new method for detecting S. aureus DNA by employing Au NP in a colorimetric assay. This technique offers quick detection, taking only 10–15 minutes (min), with a noticeable colour shift that can be observed both visually and through UV-Vis spectroscopy. The assay’s sensitivity surpassed that of the PCR method, detecting DNA at lower concentrations (8.73 ng/μL compared to 30 ng/μL). The method demonstrated a broad linear detection range, high specificity, and precise accuracy in identifying S. aureus DNA, with Au NPs having a higher aspect ratio proving particularly advantageous. Additionally, this approach proved effective in quantifying target DNA in food and clinical samples, suggesting its potential for on-site detection of S. aureus.

A variety of organic and biological targeting agents have been synthesized to specifically detect bacteria and attached to Au NPs, enabling both visual and spectrometric detection of bacteria. For example, Dr DeGrasse developed specific oligonucleic acids called “aptamers” for the enterotoxin B protein found in S. aureus. This specifically selected DNA sequence was intended to selectively bind to enterotoxin B and thus recognize S. aureus [56]. Dr Chen and co-workers attempted to colorimetrically detect S. aureus by attaching the selected aptamer for enterotoxin B protein to Au NPs [64]. DNA or RNA aptamers have been produced by Cell-Systematic Evolution of Ligands by Exponential Enrichment (Cell-SELEX) technology to select aptamers for S. aureus and its methicillin-resistant isolate [65, 66, 67, 68]. Recently, ligands containing boronic acid groups have been extensively used to increase the selectivity and sensitivity in bacterial detection. For example, Dr Wang and co-workers used disulphide phenylboronic acid on Au NPs and used this conjugated structure for colorimetric determination of S. aureus. Disulphide phenylboronic acids on gold nano-spheres bind covalently to cis-diol groups on glycans, forming the wall of S. aureus and stable complexes. However, the biggest disadvantage of the system is that there is only one boronic acid unit in the disulphide phenylboronic acid used and it also weakens the selectivity, sensitivity and binding strength of the system to bacteria [69].

2.2 Catalytic activity-based colorimetric detection of Staphylococcus aureus

S. aureus is a leading cause of both healthcare-associated and community-acquired infections. This bacterium poses a significant health risk due to its virulence factors, including endotoxins, which can lead to severe conditions such as endocarditis, pneumonia, meningitis, toxic shock syndrome, and sepsis. Prompt identification of the infection is crucial for effective treatment. Several diagnostic approaches exist for detecting pathogenic bacteria, including culture methods, biochemical assays, enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR) [70].

All of these techniques are limited by their lengthy processing times, low sensitivity, and the need for intricate sample preparation [71]. Consequently, there is an urgent need for a highly sensitive and rapid approach to detect S. aureus effectively. Recently, there has been extensive research into biosensors. In contrast to conventional techniques, nanotechnology-based biosensors offer enhanced speed, improved efficiency, and greater accuracy [72].

Peroxidase-mimicking activity has gained significant attention for identifying pathogenic bacteria because it offers benefits like cost-effectiveness, ease of use, quick results, and no need for costly instruments. The appearance of a blue colour, resulting from the catalytic oxidation of 3,3′,5,5′-tetramethylbenzidine (TMB) by H2O2 in a paper-based assay, is easily observable with the naked eye. Hence, there is a pressing demand for developing a novel colorimetric technique for the precise and selective identification of pathogenic microorganisms. Colorimetric biosensors, which rely on observable colour changes, are highly effective for detecting a wide range of targets and biomolecules. Their appeal lies in their visible colour shifts, straightforward operation, and rapid results [73].

Peroxidases represent a broad category of enzymes that facilitate the oxidation-reduction reactions dependent on H2O2, thereby mitigating the harmful effects of peroxides and certain aromatic compounds (electron donors). Additionally, these enzymes can drive the transformation of chromogenic substrates into coloured products that can be measured using spectrophotometric techniques. Consequently, peroxidases are extensively utilized in biochemical assays [74]. Hosseini [75] introduced a novel, rapid, and highly sensitive colorimetric approach for detecting S. aureus by utilizing DNA-templated nanoclusters as bioreceptors to identify whole bacterial cells for the first time. The method is highly specific to S. aureus because the aptamers in the nanoclusters bind only to S. aureus, while other bacteria like Salmonella Typhimurium, Escherichia coli, and Pseudomonas aeruginosa do not trigger the same response. This technique was successfully employed for the selective detection of bacterial cells in samples of milk, orange juice, and human serum, ensuring accurate detection even in complex samples.

The present study is a straightforward and dependable colorimetric assay for the sensitive and selective detection of S. aureus, utilizing IgY-Fe3O4/Au nanocomposites as capture probes and apt-AuNPs as optical signal enhancers. The assay leverages the enhanced catalytic properties of Au NPs, achieved through etching, combined with a TMB/H2O2 reporting system. This approach significantly improves the catalytic performance of the modified Au NPs, leading to a greater signal difference between positive and negative samples. The IgY antibodies and thiol-modified aptamers are specifically designed to target and bind to unique surface proteins of S. aureus. This selective binding inhibits the catalytic activity of the modified Au NPs, ensuring that only the presence of S. aureus leads to the observed colorimetric response, allowing for precise detection even in complex matrices. S. aureus detection is possible with a low limit of detection (LOD) of 10 CFU/mL and a broad linear range extending from 10 to 106 CFU/mL. Yao et al. [76] developed a colorimetric immunoassay for rapid S. aureus detection that incorporates etching-enhanced peroxidase-like activity of Au NPs, utilizing IgY-Fe3O4/Au nanocomposites and apt-AuNPs to amplify optical signals. This method facilitates easy visual detection of S. aureus at a minimal LOD of 10 CFU/mL and covers a wide detection range from 10 to 106 CFU/mL as shown in Figure 1.

Figure 1.

Schematic of a colorimetric assay for detecting S. aureus using etching-enhanced gold nanoparticles with IgY-Fe3O4/Au nanocomposites and apt-AuNPs for improved signal differentiation [76].

Zhang et al. [77] developed a single-step colorimetric assay for detecting S. aureus by utilizing the peroxidase-like activity of Apt-Fe3O4/Au nanocomposites (NCs), achieving high specificity through the aptamer’s selective binding to a unique S. aureus surface target, with a low detection limit of 10 CFU/mL and a broad linear range from 10 to 106 CFU/mL in just 12 minutes. Gao et al. [78] successfully developed porous nanozymes with an Au core and platinum (Pt) shell (Au@PtNEs) that exhibit high peroxidase-like activity and robustness. They employed a double-recognition colorimetric assay that does not require washing for the rapid and specific detection of S. aureus. This approach achieved a detection limit of 40 CFU/mL and covered a range from 5 x 10−1 to 5 x 10−5 CFU/mL within 1.5 hours.

Liu et al. [79] engineered a new multimetal hybrid Fe3O4-Ag-MnO2 NC, using trisodium citrate for stabilization. They successfully created spherical Fe3O4 NPs that are stable, water-soluble, and decorated with carboxyl groups. The resulting colorimetric technique proved highly effective for detecting S. aureus in various food matrices. Additionally, they developed a smartphone-based colorimetric platform employing an enzyme cascade amplification strategy to identify S. aureus in milk. This system involved a cascade bio-nanozyme setup with glucose oxidase (GOx) immobilized on Fe3O4@Ag. The method utilized a cascade reaction initiated by H2O2, generated through glucose oxidation by GOx, and subsequent colour generation through the natural peroxidase-like activity of Fe3O4@Ag with TMB. S. aureus detection was feasible through visual inspection and smartphone measurement, with the platform achieving a low detection limit of 6.9 CFU/mL in just 50 min and demonstrating commendable specificity and sensitivity.

Duan et al. [80] introduced an innovative nanozyme, PHCS@CuNcPOPTP, which exhibits light-responsive oxidase-like activity through a unique chain-linking approach. This organic-inorganic hybrid nanocomposite was synthesized using a single-step Friedel-Crafts alkylation reaction. The resulting material demonstrated exceptional light-driven catalytic properties due to its distinctive sensitivity to light. PHCS@CuNcPOPTP served as a base for constructing various signal probes, such as PHCS@CuNcPOPTP@Au-Ab2/DNA1, PHCS@CuNcPOPTP@Au-DNA1, and PHCS@CuNcPOPTP@Au-DNA2, which incorporated rabbit anti-S. aureus Rosenbach tropina antibody (bs-4582R, Ab2), DNA1, and DNA2, respectively. By repeatedly hybridizing DNA with these probes, a large quantity of PHCS@CuNcPOPTP-DNA dendrimers was generated, facilitating a chromogenic reaction without needing high H2O2 concentrations. This approach led to significant catalytic enhancement and minimized background interference. The resulting detection system demonstrated high sensitivity with a broad linear range (from 101 to 108 CFU/mL) and an impressive limit of detection (LOD) of 3.40 CFU/mL.

2.3 Paper-based colorimetric detection of Staphylococcus aureus

Paper is often the preferred substrate in biosensor design. It has many advantages [81, 82, 83]. Paper is easy to access and cost-effective. These properties make it suitable for large-scale production. Due to its lightweight nature, it can be easily transported and stored. The cellulosic structure of paper allows molecules to be carried by capillary action. This permits aptamers, antibodies, and various biomolecules to migrate easily. Therefore, paper as a substrate can be easily modified into a sensor. In addition, paper-based sensors can be easily disposed of without the risk of biohazard contamination from incineration.

Microfluidic devices were first developed in 1979 [84]. They allow measurements to be taken from the sample on a micrometer scale. Multiple functions such as sample introduction, mixing, reaction and signal output can operate in one single unit. The advantages include miniaturization, a smaller sample volume requirement, a lower consumption of materials and a lower cost. It also allows point-of-care (POC)/point-of-use (POU) diagnostics with lab-on-a-chip technology. The development of microfluidic devices has been in the direction of paper-based microfluidics for improved sensitivity, selectivity, and portability. In particular, paper-based microfluidic analytical devices (μPAD) have played an important role in the development of biosensor devices in low-resource settings (e.g. LMICs) since it was first proposed by the Whitesides group in 2007 [85].

As a result of developments, μPADs generate a signal output using a variety of sensing methods such as magnetic, optical, distance, and temperature-based readout. These sensing capabilities allow them to detect microorganisms as whole cells. In addition, pathogen nucleic acids and other biomarkers such as antigens, metabolites and toxins can also be detected using these techniques. Following the publication by the Whitesides group [86], it is now possible to sensitively detect pathogens in a wide range of samples.

Over the past decades, since μPAD was first reported by the Whitesides group in 2007 [85], studies have shown that its potential for mass production and commercialization is very promising. In addition to being cost-effective, accessible and stable, its porous structure allows for easy modification with various chemical and biological reagents. The capillary effect allows the movement of molecules without the need for an external power supply. The white background color allows excellent colorimetric detection and makes the difference visible to the eye [81, 82, 83].

μPAD can provide colourimetric, fluorescent and chemiluminescent signals by optical [86, 87, 88, 89, 90] and electrochemical [91, 92] methods. Sensitivity and selectivity have been enhanced by the use of technologies such as nanotechnology and the CRISPR/Cas system. Thus, there has been an expansion in the areas of application for μPAD. Suea-Ngam et al. [90] developed a colorimetric test for the detection of MRSA that provides rapid, sensitive and quantitative results. The colorimetric test was developed as a silver nanoplate (Ag NPls)-based μPAD. The researchers were able to obtain a qualitative colourimetric result with the naked eye. They were also able to perform a quantitative analysis using a smartphone camera. The test gives results in 30 min and a linear response (R2 = 0.994) was obtained between 1 and 104 copies.

A new generation of NM-based detection methods has been developed with the advance of technologies such as microfluidics and NMs. Paper-based sensors prepared in the form of lateral flow assays (LFA) provide colorimetric results with NMs. In particular, Au NPs and silver nanoparticles (Ag NP) are used. The localized surface plasmon resonance (LSPR) properties of the mentioned metallic NPs are utilized. For example, Lu et al. developed an aptamer-based LFA test for the detection of S. Typhimurium, E. coli O157:H7, and S. aureus. The color change is based on AuNPs. The ability of AuNPs to appear red in colloidal form and purple in aggregated form has been utilized. Colorimetric response can be observed by eye after 10 min incubation [93, 94].

Guo et al. [95] developed a test for the detection of pathogens in infected wounds that can perform rapid sampling, photocontrolled release and SERS detection. The triple-function adhesive tape can detect P. aeruginosa and S. aureus. It can detect bacteria directly from the wound after several hours of incubation. This test shows great promise for use as a POC test device.

Wang et al. [96] studied the simultaneous detection of Acinetobacter baumannii (AB), E.coli (EC) and multidrug-resistant S. aureus (SA). The developed test provides results in 35 min and is a μPAD containing dual aptamers. In the developed test, aptamers were first fixed to the paper layer of the sensor by UV crosslinking and blocking. Secondly, an aptamer-biotin conjugate was conjugated. Finally, HRP-streptavidin and TMB were applied. A blue color change was observed in the presence of bacteria. The LOD was visible to the naked eye even at 10-fold serial dilutions.

Nanoclusters have been used for the detection of S. aureus due to their nanozyme activity. Bagheri Pebdeni et al. synthesized Au/Pt bimetallic nanoclusters using cytosine-rich single-stranded DNA for the detection of S. aureus. Au/Pt bimetallic nanoclusters oxidized TMB in the presence of H2O2 due to their peroxidation properties. When TMB is oxidized, specific areas of the sensor change color from clear to dark blue. The catalytic activity of the nanoclusters is reduced in the presence of bacteria. This leads to the production of less oxidized TMB, and consequently, the intensity of the blue color decreases [75]. The working mechanism of this paper-based sensor is shown in Figure 2.

Figure 2.

Schematic of a paper-based sensor with Au/Pt bimetallic nanoclusters for detecting S. aureus, demonstrating reduced colour intensity due to decreased catalytic activity in the presence of bacteria [75].

Suaifan et al. developed an assay based on the proteolytic activity of S. aureus. The assay detects proteolytic activity using a magnetic nanobond peptide probe immobilized on a gold platform [97].

A paper-based sensor array capable of detecting sepsis in children was developed by Sheini et al. The working mechanism of the sensor array is based on measuring changes in the optical or electrical properties of the indicator after interaction with bacteria or metabolites released during bacterial growth. Au and Ag metal nanoclusters were immobilized on Whatman paper. The developed sensor was used to detect pathogens in pediatric serum samples. It detects sepsis-causing bacteria such as S. aureus, Streptococcus pyogenes, E. coli, and P. aeruginosa. Changes in fluorescence emission intensity in the presence of the pathogen were recorded in less than 15 seconds using a UV lamp and a smartphone. The researchers quantitatively analyzed the color changes using ImageJ software. The detection limit was 80 CFU/mL and a linear calibration curve was obtained in the range 102–108 CFU/mL. This test enables the diagnosis of bacteria in human serum and the detection of S. aureus in food samples such as milk, orange juice, and human serum [98]. The colorimetric changes of this sensor array in the presence of bacteria are shown in Figure 3.

Figure 3.

A fluorimetric, paper-based sensor array for the detection of paediatric sepsis, utilizing Au and Ag nanoclusters to detect sepsis-causing bacteria such as S. aureus, S. pyogenes, E. Coli and P. aeruginosa in serum samples. The figure shows (a) the layout of the sensor array, (b) the fluorescence emission changes recorded upon exposure to bacteria, and (c) the quantitative analysis of colour changes using ImageJ software [98].

In a study by Sekar et al. in 2024, 6 different pathogens were detected using glucose-functionalized gold nanoparticles. Phyto-synthesized AuNPs (Glu-AuNPs) act as transducers. The color intensity of the paper-based colorimetric sensor increased with bacterial concentration and was measured with Adobe Photoshop software. This sensor is suitable for measurement of real samples [99].

Another study in the same year developed a novel paper biosensor based on a polydiacetylene (PDA) polymer functionalized with fibrinogen (Figure 4) [100]. The fluorophore property is released by proteins that bind to fibrinogen on the surface of S. aureus. The binding causes the PDA to bend, resulting in changes in color and fluorescence. The detection limit was 50.1 CFU/mL for S. aureus-contaminated food samples and 65.0 CFU/mL for the pure S. aureus culture. Mechanism of the working principle is shown in Figure 4.

Figure 4.

Fabrication steps and working mechanism of a paper-based biosensor for S. aureus detection, utilizing a polydiacetylene (PDA) polymer functionalized with fibrinogen, resulting in colour and fluorescence changes upon bacterial binding [100].

In one of the recent studies, direct loop-mediated isothermal amplification (LAMP) and LFA were combined to detect S. aureus. The limit of detection was 102 CFU/ml with no cross-reactivity with other strains. POC technologies can become more widespread thanks to this developed system. It has advantages such as short test time, high sensitivity and user-friendly application [101].

Advertisement

3. Conclusion

Pathogenic (disease-causing) bacteria, especially those in the gram-positive group, very easily live and multiply in the environment and cause serious diseases. Studies have shown that S. aureus colonizes in nose and throat mucosa of ~30% and ~ 20% of healthy people, respectively. S. aureus has created isolates resistant to antibiotics, resulting in infections that are very difficult to treat and can lead to death. Detection and elimination of these bacteria are important not only for human and animal health, but also for industrial and plant production safety. Therefore, this review focuses on recent studies on the development of new diagnostic tests for the detection of S. aureus and MRSA pathogens with NMs with unique electrical, optical, catalytic, and pH indicators. We also discussed ideal tests that can rapidly, accurately, sensitively and selectively detect these bacteria.

References

  1. 1. American Academy of Pediatrics. Staphylococcus aureus. In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, editors. Red Book: 2021-2024 Report of the Committee on Infectious Diseases. 32nd ed. Itasca, IL: American Academy of Pediatrics; 2021. p. 678
  2. 2. Tasneem U, Mehmood K, Majid M, Ullah SR, Andleeb S. Methicillin resistant Staphylococcus aureus: A brief review of virulence and resistance. JPMA. The Journal of the Pakistan Medical Association. 2022;72(3):509-515. DOI: 10.47391/jpma.0504
  3. 3. Bai AD, Lo CK, Komorowski AS, Suresh M, Guo K, Garg A, et al. Staphylococcus aureus bacteraemia mortality: A systematic review and meta-analysis. Clinical Microbiology and Infection. 2022;28(8):1076-1084. DOI: 10.1016/j.cmi.2022.03.015
  4. 4. Campbell AJ, Al Yazidi LS, Phuong LK, Leung C, Best EJ, Webb RH, et al. Pediatric Staphylococcus aureus bacteremia: Clinical spectrum and predictors of poor outcome. Clinical Infectious Diseases. 2022;74(4):604-613. DOI: 10.1093/cid/ciab510
  5. 5. McMullan BJ, Campbell AJ, Blyth CC, McNeil JC, Montgomery CP, Tong SY, et al. Clinical management of Staphylococcus aureus bacteremia in neonates, children, and adolescents. Pediatrics. 2020;146(3):1-13. DOI: 10.1542/peds.2020-0134
  6. 6. Southwick KL, Greenko J, Quinn MJ, Haley VB, Adams E, Lutterloh E. Methicillin-resistant Staphylococcus aureus (MRSA) clusters in neonatal intensive care units (NICUs) and other neonatal units in New York state (NYS), 2001 to 2017. American Journal of Infection Control. 2024;52(4):424-435. DOI: 10.1016/j.ajic.2023.09.015
  7. 7. The Centers for Disease Control and Prevention. Recommendations for Prevention and Control of Infections in Neonatal Intensive Care Unit Patients: Staphylococcus aureus. 2020. Available from: https://www.cdc.gov/infection-control/hcp/nicu-saureus/? [Accessed: September 2, 2024]
  8. 8. Batt CA. Materials science. Food pathogen detection. Science (New York, N.Y.). 2007;316(5831):1579-1580. DOI: 10.1126/science.114072
  9. 9. Dykman L, Khlebtsov N. Gold nanoparticles in biomedical applications: Recent advances and perspectives. Chemical Society Reviews. 2012;41(6):2256-2282. DOI: 10.1039/C1CS15166E
  10. 10. Saha K, Agasti SS, Kim C, Li X, Rotello VM. Gold nanoparticles in chemical and biological sensing. Chemical Reviews. 2012;112(5):2739-2779. DOI: 10.1021/cr2001178
  11. 11. Zeng S, Yong KT, Roy I, Dinh XQ, Yu X, Luan F. A review on functionalized gold nanoparticles for biosensing applications. Plasmonics. 2011;6:491-506. DOI: 10.1007/s11468-011-9228-1
  12. 12. Gao J, Liu D, Wang Z. Screening lectin-binding specificity of bacterium by lectin microarray with gold nanoparticle probes. Analytical Chemistry. 2010;82(22):9240-9247. DOI: 10.1021/ac1022309
  13. 13. Madonna AJ, Basile F, Furlong E, Voorhees KJ. Detection of bacteria from biological mixtures using immunomagnetic separation combined with matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Rapid Communications in Mass Spectrometry. 2001;15(13):1068-1074. DOI: 10.1002/rcm.344
  14. 14. Yamaguchi N, Sasada M, Yamanaka M, Nasu M. Rapid detection of respiring Escherichia coli O157: H7 in apple juice, milk, and ground beef by flow cytometry. Cytometry Part A: the Journal of the International Society for Analytical Cytology. 2003;54(1):27-35. DOI: 10.1002/cyto.a.10045
  15. 15. Glynn B, Lahiff S, Wernecke M, Barry T, Smith TJ, Maher M. Current and emerging molecular diagnostic technologies applicable to bacterial food safety. International Journal of Dairy Technology. 2006;59(2):126-139. DOI: 10.1111/j.1471-0307.2006.00253.x
  16. 16. Celik C, Can Sezgin G, Kocabas UG, Gursoy S, Ildiz N, Tan W, et al. Novel anthocyanin-based colorimetric assay for the rapid, sensitive, and quantitative detection of helicobacter pylori. Analytical Chemistry. 2021;93(15):6246-6253. DOI: 0.1021/acs.analchem.1c00663
  17. 17. Celik C, Ildiz N, Kaya MZ, Kilic AB, Ocsoy I. Preparation of natural indicator incorporated media and its logical use as a colorimetric biosensor for rapid and sensitive detection of methicillin-resistant Staphylococcus aureus. Analytica Chimica Acta. 2020;1128:80-89. DOI: 10.1016/j.aca.2020.06.005
  18. 18. Celik C, Ildiz N, Sagiroglu P, Atalay MA, Yazici C, Ocsoy I. Preparation of nature inspired indicator based agar for detection and identification of MRSA and MRSE. Talanta. 2020;219:121292. DOI: 10.1016/j.talanta.2020.121292
  19. 19. Celik C, Demir NY, Duman M, Ildiz N, Ocsoy I. Red cabbage extract-mediated colorimetric sensor for swift, sensitive and economic detection of urease-positive bacteria by naked eye and smartphone platform. Scientific Reports. 2023;13(1):2056. DOI: 10.1038/s41598-023-28604-1
  20. 20. Celik C, Kalin G, Cetinkaya Z, Ildiz N, Ocsoy I. Recent advances in colorimetric tests for the detection of infectious diseases and antimicrobial resistance. Diagnostics. 2023;13(14):2427. DOI: 10.3390/diagnostics13142427
  21. 21. Sezgin GC, Ocsoy I. Anthocyanin-rich black carrot (Daucus carota ssp. sativus var. atrorubens Alef.) and red cabbage (Brassica oleracea) extracts incorporated biosensor for colorimetric detection of helicobacter pylori with color image processing. Brazilian Journal of Microbiology. 2023;54(2):897-905. DOI: 10.1007/s42770-023-00989-1
  22. 22. Sezgin GC, Tekin YE, Calim B, Celik C, Alrifai W, Temur N, et al. Development of a colorimetric urease test based on Au NPs capped with anthocyanin for the rapid detection of helicobacter pylori through multiple readouts. ChemistrySelect. 2023;8(27):e202300637. DOI: 10.1002/slct.202300637
  23. 23. Shimada T, Ookubo K, Komuro N, Shimizu T, Uehara N. Blue-to-red chromatic sensor composed of gold nanoparticles conjugated with thermoresponsive copolymer for thiol sensing. Langmuir. 2007;23(22):11225-11232. DOI: 10.1021/la700664u
  24. 24. Thaxton CS, Georganopoulou DG, Mirkin CA. Gold nanoparticle probes for the detection of nucleic acid targets. Clinica Chimica Acta. 2006;363(1-2):120-126. DOI: 10.1016/j.cccn.2005.05.042
  25. 25. Schofield CL, Haines AH, Field RA, Russell DA. Silver and gold glyconanoparticles for colorimetric bioassays. Langmuir. 2006;22(15):6707-6711. DOI: 10.1021/la060288r
  26. 26. Shukoor MI, Altman MO, Han D, Bayrac AT, Ocsoy I, Zhu Z, et al. Aptamer-nanoparticle assembly for logic-based detection. ACS Applied Materials & Interfaces. 2012;4(6):3007-3011. DOI: 10.1021/am300374q
  27. 27. Unal IS, Demirbas A, Onal I, Ildiz N, Ocsoy I. One step preparation of stable gold nanoparticle using red cabbage extracts under UV light and its catalytic activity. Journal of Photochemistry and Photobiology B: Biology. 2020;204:111800. DOI: 10.1016/j.jphotobiol.2020.111800
  28. 28. Demirbas A, Büyükbezirci K, Celik C, Kislakci E, Karaagac Z, Gokturk E, et al. Synthesis of long-term stable gold nanoparticles benefiting from red raspberry (Rubus idaeus), strawberry (Fragaria ananassa), and blackberry (Rubus fruticosus) extracts–gold ion complexation and investigation of reaction conditions. ACS Omega. 2019;4(20):18637-18644. DOI: 10.1021/acsomega.9b02469
  29. 29. McLamore ES, Convertino M, Ocsoy I, Vanegas DC, Taguchi M, Rong Y, et al. Biomimetic fractal nanometals as a transducer layer in electrochemical biosensing. In: Semiconductor-Based Sensors. Singapore: World Scientific Publishing Co. Pte. Ltd.; 2017. pp. 35-67. DOI: 10.1142/9789813146730_0002
  30. 30. Howden BP, Giulieri SG, Wong Fok Lung T, Baines SL, Sharkey LK, Lee JY, et al. Staphylococcus aureus host interactions and adaptation. Nature Reviews Microbiology. 2023;21(6):380-395. DOI: 10.1038/s41579-023-00852-y
  31. 31. Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG Jr. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2015;28(3):603-661. DOI: 10.1128/cmr.00134-14
  32. 32. Gherardi G. Staphylococcus aureus infection: Pathogenesis and antimicrobial resistance. International Journal of Molecular Sciences. 2023;24(9):8182. DOI: 10.3390/ijms24098182
  33. 33. DeLeo FR, Diep BA, Otto M. Host defense and pathogenesis in Staphylococcus aureus infections. Infectious Disease Clinics of North America. 2009;23(1):17-34. DOI: 10.1016/j.idc.2008.10.003
  34. 34. Renduchintala K, Nanjappa S, Ramsakal A, Greene J. Successful treatment of community-acquired methicillin-resistant Staphylococcus aureus necrotizing pneumonia in the setting of chronic graft-versus-host disease. Cureus. 2021;13(2):e13123. DOI: 10.7759/cureus.13123
  35. 35. Rasul S, Farhat F, Asnake SA. Severe MRSA necrotizing pneumonia. Infection. 2013;41(1):299-300. DOI: 10.1007/s15010-012-0267-0
  36. 36. Samia NI, Robicsek A, Heesterbeek H, Peterson LR. Methicillin-resistant Staphylococcus aureus nosocomial infection has a distinct epidemiological position and acts as a marker for overall hospital-acquired infection trends. Scientific Reports. 2022;12(1):17007. DOI: 10.1038/s41598-022-21300-6
  37. 37. Rocha LEC, Singh V, Esch M, Lenaerts T, Liljeros F, Thorson A. Dynamic contact networks of patients and MRSA spread in hospitals. Scientific Reports. 2020;10(1):9336. DOI: 10.1038/s41598-020-66270-9
  38. 38. Galar A, Weil AA, Dudzinski DM, Muñoz P, Siedner MJ. Methicillin-resistant Staphylococcus aureus prosthetic valve endocarditis: Pathophysiology, epidemiology, clinical presentation, diagnosis, and management. Clinical Microbiology Reviews. 2019;32(2):e00041-e00018. DOI: 10.1128/cmr.00041-18
  39. 39. Rupp M, Walter N, Bärtl S, Heyd R, Hitzenbichler F, Alt V. Fracture-related infection—Epidemiology, Etiology, diagnosis, prevention, and treatment. Deutsches Ärzteblatt International. 2024;121(1):17. DOI: 10.3238/arztebl.m2023.0233
  40. 40. Monk EJ, Jones TP, Bongomin F, Kibone W, Nsubuga Y, Ssewante N, et al. Antimicrobial resistance in bacterial wound, skin, soft tissue and surgical site infections in central, eastern, southern and Western Africa: A systematic review and meta-analysis. PLOS Global Public Health. 2024;4(4):e0003077. DOI: 10.1371/journal.pgph.0003077
  41. 41. Baker AW, Dicks KV, Durkin MJ, et al. Epidemiology of surgical site infection in a community hospital network. Infection Control & Hospital Epidemiology. 2016;37(5):519-526. DOI: 10.1017/ice.2016.13
  42. 42. Zhu Z, Hu Z, Li S, Fang R, Ono HK, Hu D-L. Molecular characteristics and pathogenicity of Staphylococcus aureus exotoxins. International Journal of Molecular Sciences. 2024;25(1):395. DOI: 10.3390/ijms25010395
  43. 43. Kanjilal S, Sater MR, Thayer M, Lagoudas GK, Kim S, Blainey PC, et al. Trends in antibiotic susceptibility in Staphylococcus aureus in Boston, Massachusetts, from 2000 to 2014. Journal of Clinical Microbiology. 2018;56(1):10-128. DOI: 10.1128/JCM.01160-17
  44. 44. Aggarwal S, Jena S, Panda S, Sharma S, Dhawan B, Nath G, et al. Antibiotic susceptibility, virulence pattern, and typing of Staphylococcus aureus strains isolated from variety of infections in India. Frontiers in Microbiology. 2019;10:2763. DOI: 10.3389/fmicb.2019.02763
  45. 45. Li J, Echevarria KL, Hughes DW, Cadena JA, Bowling JE, Lewis JS. Comparison of cefazolin versus oxacillin for treatment of complicated bacteremia caused by methicillin-susceptible Staphylococcus aureus. Antimicrobial Agents and Chemotherapy. 2014;58(9):5117-5124. DOI: 10.1128/AAC.02800-14
  46. 46. Dutra KJ, Lazenby GB, Goje O, Soper DE. Cefazolin as the mainstay for antibiotic prophylaxis in patients with a penicillin allergy in obstetrics and gynecology. American Journal of Obstetrics and Gynecology. 2024;231(4):430-436. DOI: 10.1016/j.ajog.2024.03.019
  47. 47. Bavaro DF, Belati A, Bussini L, Cento V, Diella L, Gatti M, et al. Safety and effectiveness of fifth generation cephalosporins for the treatment of methicillin-resistant Staphylococcus aureus bloodstream infections: A narrative review exploring past, present, and future. Expert Opinion on Drug Safety. 2024;23(1):9-36. DOI: 10.1080/14740338.2023.2299377
  48. 48. Binda E, Marinelli F, Marcone GL. Old and new Glycopeptide antibiotics: Action and resistance. Antibiotics. 2014;3(4):572-594. DOI: 10.3390/antibiotics3040572
  49. 49. Claeys KC, Zasowski EJ, Casapao AM, Lagnf AM, Nagel JL, Nguyen CT, et al. Daptomycin improves outcomes regardless of vancomycin MIC in a propensity-matched analysis of methicillin-resistant Staphylococcus aureus bloodstream infections. Antimicrobial Agents and Chemotherapy. 2016;60(10):5841-5848. DOI: 10.1128/AAC.00227-16
  50. 50. Schweizer ML, Richardson K, Vaughan Sarrazin MS, Goto M, Livorsi DJ, Nair R, et al. Comparative effectiveness of switching to daptomycin versus remaining on vancomycin among patients with methicillin-resistant Staphylococcus aureus (MRSA) bloodstream infections. Clinical Infectious Diseases. 2021;72(Supplement. 1):S68-S73. DOI: 10.1093/cid/ciaa1572
  51. 51. Guskey MT, Tsuji BT. A comparative review of the lipoglycopeptides: Oritavancin, dalbavancin, and telavancin. Pharmacotherapy. 2010;30(1):80-94. DOI: 10.1592/phco.30.1.80
  52. 52. Moellering RC Jr. Linezolid: The first oxazolidinone antimicrobial. Annals of Internal Medicine. 2003;139(10):864. DOI: 10.7326/0003-4819-138-2-200301210-00015
  53. 53. Kaushik A, Kest H, Sood M, Steussy BW, Thieman C, Gupta S. Biofilm producing methicillin-resistant Staphylococcus aureus (MRSA) infections in humans: Clinical implications and management. Pathogens. 2024;13(1):76. DOI: 10.3390/pathogens13010076
  54. 54. Sanchini A. Recent developments in phenotypic and molecular diagnostic methods for antimicrobial resistance detection in Staphylococcus aureus: A narrative review. Diagnostics. 2022;12(1):208. DOI: 10.3390/diagnostics12010208
  55. 55. Kim JK, Yun HY, Kim JS, Kim W, Lee CS, Kim BG, et al. Development of fluorescence-linked immunosorbent assay for rapid detection of Staphylococcus aureus. Applied Microbiology and Biotechnology. 2024;108(1):2. DOI: 10.1007/s00253-023-12836-2. Epub 2023 Dec 28
  56. 56. Duan R, Wang P. Rapid and simple approaches for diagnosis of in bloodstream infections. Polish Journal of Microbiology. 2022;71(4):481-489. DOI: 10.33073/pjm-2022-050
  57. 57. Gill AA, Singh S, Thapliyal N, Karpoormath R. Nanomaterial-based optical and electrochemical techniques for detection of methicillin-resistant Staphylococcus aureus: A review. Microchimica Acta. 2019;186:1-9. DOI: 10.1007/s00604-018-3186-7
  58. 58. Alberti G, Zanoni C, Magnaghi LR, Biesuz R. Gold and silver nanoparticle-based colorimetric sensors: New trends and applications. Chem. 2021;9(11):305. DOI: 10.3390/chemosensors9110305
  59. 59. Shahbazi R, Salouti M, Amini B, Jalilvand A, Naderlou E, Amini A, et al. Highly selective and sensitive detection of Staphylococcus aureus with gold nanoparticle-based core-shell nano biosensor. Molecular and Cellular Probes. 2018;41:8-13. DOI: 10.1016/j.mcp.2018.07.004
  60. 60. Khan MQ, Khan J, Alvi MA, Nawaz H, Fahad M, Umar M. Nanomaterial-based sensors for microbe detection: A review. Discover Nano. 2024;19(1):120. DOI: 10.1186/s11671-024-04065-x
  61. 61. Choi Y, Hwang JH, Lee SY. Recent trends in nanomaterials-based colorimetric detection of pathogenic bacteria and viruses. Small Methods. 2018;2(4):1700351. DOI: 10.1002/smtd.201700351
  62. 62. Najafabad MB, Rastin SJ, Taghvaei F, Khiyavi AA. A review on applications of gold nanoparticles-based biosensor for pathogen detection. Advances in Natural Sciences: Nanoscience and Nanotechnology. 2022;13(3):033002. DOI: 10.1088/2043-6262/ac79ae
  63. 63. Yuan J, Wu S, Duan N, Ma X, Xia Y, Chen J, et al. A sensitive gold nanoparticle-based colorimetric aptasensor for Staphylococcus aureus. Talanta. 2014;127:163-168. DOI: 10.1016/j.talanta.2014.04.013
  64. 64. Liu A, Zhang Y, Chen W, Wang X, Chen F. Gold nanoparticle-based colorimetric detection of staphylococcal enterotoxin B using ssDNA aptamers. European Food Research and Technology. 2013;237:323-329. DOI: 10.1007/s00217-013-1995-9
  65. 65. Zhang Y, Chen Y, Han D, Ocsoy I, Tan W. Aptamers selected by cell-SELEX for application in cancer studies. Bioanalysis. 2010;2(5):907-918. DOI: 10.4155/bio.10.46
  66. 66. Arslan Ocsoy M, Yusufbeyoglu S, Ildiz N, Ulgen A, Ocsoy I. DNA aptamer-conjugated magnetic graphene oxide for pathogenic bacteria aggregation: Selective and enhanced photothermal therapy for effective and rapid killing. ACS Omega. 2021;6(31):20637-20643. DOI: 10.1021/acsomega.1c02832
  67. 67. Turek D, Van Simaeys D, Johnson J, Ocsoy I, Tan W. Molecular recognition of live methicillin-resistant Staphylococcus aureus cells using DNA aptamers. World Journal of Translational Medicine. 2013;2(3):67-74. DOI: 10.5528/wjtm.v2.i3.67
  68. 68. Ocsoy I, Yusufbeyoglu S, Yılmaz V, McLamore ES, Ildız N, Ülgen A. DNA aptamer functionalized gold nanostructures for molecular recognition and photothermal inactivation of methicillin-resistant Staphylococcus aureus. Colloids and Surfaces B: Biointerfaces. 2017;159:16-22. DOI: 10.1016/j.colsurfb.2017.07.056
  69. 69. Wang J, Gao J, Liu D, Han D, Wang Z. Phenylboronic acid functionalized gold nanoparticles for highly sensitive detection of Staphylococcus aureus. Nanoscale. 2012;4(2):451-454. DOI: 10.1039/C2NR11657J
  70. 70. Pilecky M, Schildberger A, Knabl L, Orth-Höller D, Weber V. Influence of antibiotic treatment on the detection of S. Aureus in whole blood following pathogen enrichment. BMC Microbiology. 2019;19:1-9. DOI: 10.1186/s12866-019-1559-7
  71. 71. dos Santos SR, Corrêa CR, de Barros AL, Serakides R, Fernandes SO, Cardoso VN, et al. Identification of Staphylococcus aureus infection by aptamers directly radiolabeled with technetium-99m. Nuclear Medicine and Biology. 2015;42(3):292-298. DOI: 10.1016/j.nucmedbio.2014.12.002
  72. 72. Roth-Konforti M, Green O, Hupfeld M, Fieseler L, Heinrich N, Ihssen J, et al. Ultrasensitive detection of salmonella and listeria monocytogenes by small-molecule chemiluminescence probes. Angewandte Chemie. 2019;131(30):10469-10475. DOI: 10.1002/ange.201904719
  73. 73. Adkins JA, Boehle K, Friend C, Chamberlain B, Bisha B, Henry CS. Colorimetric and electrochemical bacteria detection using printed paper-and transparency-based analytic devices. Analytical Chemistry. 2017;89(6):3613-3621. DOI: 10.1021/acs.analchem.6b05009
  74. 74. Xu D, Wu L, Yao H, Zhao L. Catalase-like nanozymes: Classification, catalytic mechanisms, and their applications. Small. 2022;18(37):2203400. DOI: 10.1002/smll.202203400
  75. 75. Hosseini M. Fast and selective whole cell detection of Staphylococcus aureus bacteria in food samples by paper based colorimetric nanobiosensor using peroxidase-like catalytic activity of DNA-Au/Pt bimetallic nanoclusters. Microchemical Journal. 2020;159:105475. DOI: 10.1016/j.microc.2020.105475
  76. 76. Yao S, Li J, Pang B, Wang X, Shi Y, Song X, et al. Colorimetric immunoassay for rapid detection of Staphylococcus aureus based on etching-enhanced peroxidase-like catalytic activity of gold nanoparticles. Microchimica Acta. 2020;187:1-8. DOI: 10.1007/s00604-020-04473-7
  77. 77. Zhang H, Yao S, Song X, Xu K, Wang J, Li J, et al. One-step colorimetric detection of Staphylococcus aureus based on target-induced shielding against the peroxidase mimicking activity of aptamer-functionalized gold-coated iron oxide nanocomposites. Talanta. 2021;232:122448. DOI: 10.1016/j.talanta.2021.122448
  78. 78. Gao B, Ding Y, Cai Z, Wu S, Wang J, Ling N, et al. Dual-recognition colorimetric platform based on porous Au@ Pt nanozymes for highly sensitive washing-free detection of Staphylococcus aureus. Microchimica Acta. 2024;191(7):438. DOI: 10.1007/s00604-024-06460-8
  79. 79. Liu Y, Sun M, Qiao W, Cong S, Zhang Y, Wang L, et al. Multicolor colorimetric visual detection of Staphylococcus aureus based on Fe3O4–Ag–MnO2 composites nano-oxidative mimetic enzyme. Analytica Chimica Acta. 2023;1239:340654. DOI: 10.1016/j.aca.2022.340654
  80. 80. Duan B, Li B, Ma L, Niu X, Yang Y, Zhang X. Colorimetric detection of Staphylococcus aureus based on self-linkable and hollow organic-inorganic nanocomposites as light-driven oxidase-like nanozyme for cascade signal amplification. Sensors and Actuators B: Chemical. 2024;409:135547. DOI: 10.1016/j.snb.2024.135547
  81. 81. Mahadeva SK, Walus K, Stoeber B. Paper as a platform for sensing applications and other devices: A review. ACS Applied Materials & Interfaces. 2015;7(16):8345-8362. DOI: 10.1021/acsami.5b00373
  82. 82. Mao K, Min X, Zhang H, Zhang K, Cao H, Guo Y, et al. Based microfluidics for rapid diagnostics and drug delivery. Journal of Controlled Release. 2020;322:187-199. DOI: 10.1016/j.jconrel.2020.03.010
  83. 83. Pan Y, Mao K, Hui Q, Wang B, Cooper J, Yang Z. Based devices for rapid diagnosis and wastewater surveillance. TrAC Trends in Analytical Chemistry. 2022;157:116760. DOI: 10.1016/j.trac.2022.116760
  84. 84. Terry SC, Jerman JH, Angell JB. A gas chromatographic air analyzer fabricated on a silicon wafer. IEEE Transactions on Electron Devices. 1979;26(12):1880-1886. DOI: 10.1109/T-ED.1979.19791
  85. 85. Martinez AW, Phillips ST, Butte MJ, Whitesides GM. Patterned paper as a platform for inexpensive, low-volume, portable bioassays. Angewandte Chemie. 2007;119(8):1340-1342. DOI: 10.1002/anie.200603817
  86. 86. Reboud J, Xu G, Garrett A, Adriko M, Yang Z, Tukahebwa EM, et al. Based microfluidics for DNA diagnostics of malaria in low resource underserved rural communities. National Academy of Sciences of the United States of America. 2019;116(11):4834-4842. DOI: 10.1073/pnas.1812296116
  87. 87. Yang Z, Xu G, Reboud J, Ali SA, Kaur G, McGiven J, et al. Rapid veterinary diagnosis of bovine reproductive infectious diseases from semen using paper-origami DNA microfluidics. ACS Sensors. 2018;3(2):403-409. DOI: 10.1021/acssensors.7b00825
  88. 88. Ratnarathorn N, Chailapakul O, Henry CS, Dungchai W. Simple silver nanoparticle colorimetric sensing for copper by paper-based devices. Talanta. 2012;99:552-557. DOI: 10.1016/j.talanta.2012.06.033
  89. 89. Somvanshi SB, Ulloa AM, Zhao M, Liang Q, Barui AK, Lucas A, et al. Microfluidic paper-based aptasensor devices for multiplexed detection of pathogenic bacteria. Biosensors and Bioelectronics. 2022;207:114214. DOI: 10.1016/j.bios.2022.114214
  90. 90. Suea-Ngam A, Choopara I, Li S, Schmelcher M, Somboonna N, Howes PD, et al. In situ nucleic acid amplification and ultrasensitive colorimetric readout in a paper-based analytical device using silver Nanoplates. Advanced Healthcare Materials. 2021;10(7):2001755. DOI: 10.1002/adhm.202001755, 2001755
  91. 91. Dungchai W, Chailapakul O, Henry CS. Electrochemical detection for paper-based microfluidics. Analytical chemistry. 2009;81(14):5821-5826. DOI: 10.1021/ac9007573
  92. 92. Jiang H, Yang J, Wan K, Jiang D, Jin C. Miniaturized paper-supported 3D cell-based electrochemical sensor for bacterial lipopolysaccharide detection. ACS Sensors. 2020;5(5):1325-1335. DOI: 10.1021/acssensors.9b02508
  93. 93. Mandal PK, Biswas AK, Choi K, Pal UK. Methods for rapid detection of foodborne pathogens: An overview. American Journal of Food Technology. 2011;6(2):87-102. DOI: 10.3923/ajft.2011.87.102
  94. 94. Lu C, Gao X, Chen Y, Ren J, Liu C. Aptamer-based lateral flow test strip for the simultaneous detection of salmonella typhimurium, Escherichia coli O157: H7 and Staphylococcus aureus. Analytical Letters. 2020;53(4):646-659. DOI: 10.1080/00032719.2019.1663528
  95. 95. Guo J, Zhong Z, Li Y, Liu Y, Wang R, Ju H. “Three-in-one” SERS adhesive tape for rapid sampling, release, and detection of wound infectious pathogens. ACS applied Materials & Interfaces. 2019;11(40):36399-36408. DOI: 10.1021/ACSAMI.9B12823
  96. 96. Wang CH, Wu JJ, Lee GB. Screening of highly-specific aptamers and their applications in paper-based microfluidic chips for rapid diagnosis of multiple bacteria. Sensors and Actuators B: Chemical. 2019;284:395-402. DOI: 10.1016/J.SNB.2018.12.112
  97. 97. Suaifan GA, Alhogail S, Zourob M. Rapid and low-cost biosensor for the detection of Staphylococcus aureus. Biosensors and Bioelectronics. 2017;90:230-237. DOI: 10.1016/j.bios.2016.11.047
  98. 98. Sheini A. A point-of-care testing sensor based on fluorescent nanoclusters for rapid detection of septicemia in children. Sensors and Actuators B: Chemical. 2021;328:129029. DOI: 10.1016/j.snb.2020.129029
  99. 99. Sekar V, Santhanam A, Arunkumar P. A low-cost paper and solution based colorimetric detection of bacteria using glucose-functionalized gold nanoparticles. Journal of Water Process Engineering. 2024;59:105102. DOI: 10.1016/j.jwpe.2024.105102
  100. 100. Albashir D, Lu H, Gouda M, Acharya DR, Danhassan UA, Bakur A, et al. A novel polydiacetylene-functionalized fibrinogen paper-based biosensor for on-spot and rapid detection of Staphylococcus aureus. Food Chemistry. 2024;458:140291. DOI: 10.1016/j.foodchem.2024.140291
  101. 101. Lee S, Reo SH, Kim S, Kim S, Lee ES, Cha BS, et al. Colorimetric detection of Staphylococcus aureus based on direct loop-mediated isothermal amplification in combination with lateral flow assay. BioChip Journal. 2024;18(1):85-92. DOI: 10.1007/s13206-023-00130-2

Written By

Cemile Yilmaz, Cagla Celik, Nilay Ildiz, Esma Eryilmaz-Eren, Mehmet Akif Dündar, Uner Kayabas and Ismail Ocsoy

Submitted: 29 August 2024 Reviewed: 30 August 2024 Published: 26 September 2024